<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to the male with infertility
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to the male with infertility
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to the male with infertility
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Bradley D Anawalt, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter J Snyder, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alvin M Matsumoto, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Martin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 04, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2459214982">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infertility in a couple is usually defined as the inability to achieve conception despite one year of regular, unprotected intercourse. When the female partner is &gt;35 years old, infertility is defined as failure to conceive within six months of unprotected intercourse [
         <a href="#rid1">
          1
         </a>
         ]. However, up to 40 to 50 percent of young, healthy couples that fail to conceive in the first 12 months will conceive in the subsequent 12 months with no specific treatment [
         <a href="#rid2">
          2,3
         </a>
         ]. Therefore, in some circumstances, delay in extensive evaluation and treatment is reasonable. In approximately 35 percent of couples with infertility, a male factor is identified along with a female factor; in approximately 10 percent, a male factor is the only identifiable cause.
        </p>
        <p>
         While many men with male infertility have oligozoospermia (a low number of sperm cells in the ejaculate compared with reference ranges) or azoospermia (no sperm cells in the ejaculate), some infertile men have normal sperm counts. Over 80 percent of infertile men have low sperm concentrations and poor sperm quality (a decrease in sperm motility [asthenozoospermia] and/or an increase in spermatozoa with abnormal morphology [teratozoospermia]). A small percentage of infertile men have normal sperm concentrations but poor sperm quality, and another small percentage of infertile men have normal sperm concentrations and normal motility and morphology.
        </p>
        <p>
         This topic will review the evaluation of male infertility. The causes and management of male infertility and an overview of infertility are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">
          "Causes of male infertility"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2006773706">
         <span class="h1">
          CATEGORIES OF MALE INFERTILITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The causes of male infertility can be divided into four main areas  (
         <a class="graphic graphic_table graphicRef54356" href="/z/d/graphic/54356.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">
          "Causes of male infertility"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endocrine and systemic disorders with hypogonadotropic hypogonadism
         </strong>
         – 5 to 15 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Primary testicular defects in spermatogenesis
         </strong>
         – 70 to 80 percent. Klinefelter syndrome is the most common identifiable cause of a primary testicular defect, but the majority (90 to 95 percent) in this category have idiopathic dysspermatogenesis, an isolated defect in spermatogenesis without an identifiable cause.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sperm transport disorders
         </strong>
         – 2 to 5 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Idiopathic male infertility
         </strong>
         – 10 to 20 percent. Idiopathic male infertility should be distinguished from idiopathic dysspermatogenesis. Idiopathic male infertility describes an infertile man with a normal semen analysis and no apparent cause for infertility, whereas infertile men with idiopathic dysspermatogenesis have abnormal semen analyses.
        </p>
        <p>
        </p>
        <p>
         The precise epidemiology of prevalence and causes of male infertility has never been accurately assessed for several reasons, including differences in definitions of infertility, underreporting, and lack of systematic data gathering [
         <a href="#rid4">
          4,5
         </a>
         ]. The above prevalences are estimations of the proportion of men presenting for infertility treatment at a referral center and likely do not represent the prevalence in the broader community in industrialized countries, nor do these estimations reflect likely regional variations around the world [
         <a href="#rid4">
          4-6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4168872994">
         <span class="h1">
          DIAGNOSTIC APPROACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial evaluation of the male with infertility is focused on detecting the small percentage of causes that can be treated to restore normal fertility. The remainder of the evaluation of male infertility is focused on determining which couples with male factor infertility might benefit from assisted reproductive technologies (ART).
        </p>
        <p>
         Molecular biology techniques have increased the ability to identify more genetic causes of male infertility, but only a minority of infertile men have an identifiable cause (see
         <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">
          "Causes of male infertility"
         </a>
         ). The disorders in many infertile men are characterized primarily by descriptions of observed abnormalities, such as decreased sperm number, movement, or egg-penetrating and fusion capabilities. Even testicular biopsies rarely shed insight on the underlying etiology; they simply indicate the extent of spermatogenic impairment.
        </p>
        <p>
         The essential components of the evaluation of the infertile man include (see
         <a class="local">
          'Initial visit'
         </a>
         below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical examination
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Semen analysis; if abnormal, it should be repeated
        </p>
        <p>
        </p>
        <p>
         Additional components of the evaluation of the infertile man may include (see
         <a class="local">
          'Additional evaluation'
         </a>
         below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Endocrine testing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Imaging of accessory glands and ducts
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genetic tests
        </p>
        <p>
        </p>
        <p>
         The profile created by the results permits a systematic assessment of the male partner.
        </p>
        <p class="headingAnchor" id="H3208983247">
         <span class="h2">
          Initial visit
         </span>
        </p>
        <p class="headingAnchor" id="H328713180">
         <span class="h3">
          History and physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of an infertile man should begin with a detailed history that focuses on potential causes of infertility. A detailed history of the female partner should also be obtained, including menstrual history, history of previous fertility (or infertility), and any prior evaluation or treatment of infertility. For the male partner, the clinician should inquire about symptoms, prior illnesses, trauma, surgical procedures, or exposure to testicular toxins that are associated with male hypogonadism (dysspermatogenesis with or without decreased testosterone production):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sexual developmental history, including testicular descent, pubertal development, loss of body hair, or decrease in shaving frequency.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic severe systemic illness or history of major head trauma, surgery, or irradiation that could result in hypogonadotropic hypogonadism. (See
         <a class="medical medical_review" href="/z/d/html/7460.html" rel="external">
          "Causes of secondary hypogonadism in males"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infections, such as mumps orchitis, sinopulmonary symptoms, sexually transmitted infections, and genitourinary tract infections (including prostatitis).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgical procedures or significant trauma involving the pelvis and genital area.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drugs and environmental exposures that can adversely impact the hypothalamic-pituitary-testicular axis, including alcohol, tobacco, marijuana, opioids, radiation therapy, anabolic steroids, corticosteroids, cytotoxic chemotherapy (current or past), drugs that cause hyperprolactinemia, and exposure to toxic chemicals (eg, pesticides). (See
         <a class="medical medical_review" href="/z/d/html/7460.html" rel="external">
          "Causes of secondary hypogonadism in males"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sexual history, including libido, frequency of intercourse, and previous fertility assessments of the man and his partner.
        </p>
        <p>
        </p>
        <p>
         The physical examination should include a general medical examination to determine overall health, obesity, and overt signs of endocrinopathies that are uncommon causes of male infertility (eg, thyroid dysfunction or Cushing's syndrome).
        </p>
        <p>
         Because some infertile men have combined defects in testosterone and sperm production, the examination should also focus on findings suggestive of androgen deficiency. The clinical manifestations of androgen deficiency depend upon the age of onset. Androgen deficiency during early gestation presents as atypical genitalia; in late gestation as micropenis; in childhood as delayed pubertal development; and in adulthood as decreased sexual function, infertility, and, eventually, loss of secondary sex characteristics. The examination of the man should include the following components. (See
         <a class="medical medical_review" href="/z/d/html/7462.html" rel="external">
          "Clinical features and diagnosis of male hypogonadism"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin – Men with iron overload syndromes as the cause of infertility may have diffuse or patchy hyperpigmentation. Men with Cushing's syndrome may have thin skin, ecchymoses, and/or broad purple striae. Loss of pubic, axillary, and facial hair, decreased oiliness of the skin, and fine facial wrinkling suggest longstanding testosterone deficiency.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         External genitalia – The genital examination is the most important aspect of physical examination in the assessment of an infertile man. Several abnormalities that affect fertility can be recognized by examination of the external genitalia:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Incomplete sexual development can be recognized by examining the phallus and testes and finding small testes and other findings of incomplete pubertal development (Tanner stage less than 5). (See
         <a class="medical medical_review" href="/z/d/html/5849.html" rel="external">
          "Normal puberty"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diseases that affect sperm maturation and transport can be detected by examination of the scrotum for absence of the vasa, epididymal thickening, and large varicoceles. (See
         <a class="medical medical_review" href="/z/d/html/6885.html" rel="external">
          "Nonacute scrotal conditions in adults", section on 'Varicocele'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6367.html" rel="external">
          "Cystic fibrosis: Clinical manifestations and diagnosis", section on 'Infertility'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Approximately 90 percent of testicular volume consists of seminiferous tubules that make sperm, and subnormal testicular volumes correlate with decreased sperm production and sperm concentrations in the ejaculate. Decreased volume of the seminiferous tubules can be detected by measuring testicular size by Prader orchidometer or calipers. The Prader orchidometer consists of a series of plastic ellipsoids with a volume from 1 to 35 cc  (
         <a class="graphic graphic_picture graphicRef117431" href="/z/d/graphic/117431.html" rel="external">
          picture 1
         </a>
         ). In an adult man, a testicular volume less than 15 cc (as measured by Prader orchidometry) or a testicular length (measured on the longest axis) less than 3.6 cm is considered small.
        </p>
        <p>
        </p>
        <p>
         Prader orchidometry is adequate for assessment of testicular volumes in the evaluation of the infertile man [
         <a href="#rid7">
          7
         </a>
         ]. Prader orchidometry has been reported to estimate greater (approximately 25 to 30 percent) testicular volumes than those by ultrasound, and the overestimation in size is greater with smaller testicles [
         <a href="#rid8">
          8-10
         </a>
         ]. However, these studies showed a high correlation between volumes measured by Prader orchidometry and ultrasound. A systematic review confirmed that ultrasound is more accurate than the Prader orchidometer to assess testicular volume, but that measurements by both methods are closely related.
        </p>
        <p class="headingAnchor" id="H2564207924">
         <span class="h3">
          Semen analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Semen analysis is the key laboratory assessment of the male partner of an infertile couple. The standard semen analysis consists of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Semen volume and pH
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microscopy for:
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sperm concentration, count, motility, and morphology
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Debris and agglutination
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Leukocyte count
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Immature germ cells
        </p>
        <p>
        </p>
        <p>
         The semen sample should be collected after two to seven days of ejaculatory abstinence. If possible, the patient should collect the sample by masturbation at the doctor's office. If not possible, then the sample may be collected at home and delivered to the laboratory within an hour of collection.
        </p>
        <p>
         The semen analysis should be performed using standardized methods, preferably those described in the World Health Organization (WHO) Laboratory Manual for the Examination and Processing of Human Semen [
         <a href="#rid11">
          11
         </a>
         ]. In addition, the laboratory should employ internal quality control measures and participate in external quality control programs available from national andrology, clinical chemistry, and pathology societies [
         <a href="#rid11">
          11,12
         </a>
         ]. A single seminal fluid analysis suffices for the initial evaluation of male infertility, but one to two additional fluid analyses should be performed if any abnormalities are found [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3716837543">
         <span class="h4">
          Reference limits
         </span>
         <span class="headingEndMark">
          —
         </span>
         The WHO has published lower reference limits for semen analyses [
         <a href="#rid13">
          13
         </a>
         ]. The following parameters represent the generally accepted 5
         <sup>
          th
         </sup>
         percentile (lower reference limits and 95% CIs in parentheses), derived from a study of over 1900 men whose partners had a time to pregnancy of ≤12 months [
         <a href="#rid13">
          13
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Volume – 1.5 mL (95% CI 1.4-1.7)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sperm concentration – 15 million spermatozoa/mL (95% CI 12-16)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Total sperm number – 39 million spermatozoa per ejaculate (95% CI 33-46)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Morphology – 4 percent normal forms (95% CI 3-4), using "strict" Tygerberg method [
         <a href="#rid11">
          11
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vitality – 58 percent live (95% CI 55-63)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Progressive motility – 32 percent (95% CI 31-34)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Total (progressive and nonprogressive) motility – 40 percent (95% CI 38-42)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3473164154">
         <span class="h2">
          Additional evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         After the initial evaluation (history, physical examination, and semen analysis), men with infertility should undergo the following evaluation:
        </p>
        <p class="headingAnchor" id="H1417518337">
         <span class="h3">
          Men with a normal semen analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Male partners in an infertile couple may have idiopathic male infertility. Other possibilities include infertility of the female partner or a couples' infertility factor (including insufficient frequency or duration of unprotected vaginal intercourse that should occur at least one to two times weekly for optimal conception rates). After complete evaluation of the female partner and treatment of reversible causes of female infertility, the couple should consider referral to a specialist in ART, such as in vitro fertilization (IVF).
        </p>
        <p class="headingAnchor" id="H1822070730">
         <span class="h3">
          Men with an abnormal semen analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most infertile men with abnormal semen analyses have abnormalities in sperm concentrations, morphology, and motility.
        </p>
        <p class="headingAnchor" id="H1737979649">
         <span class="h4">
          Normal sperm concentration, abnormal morphology and/or motility
         </span>
         <span class="headingEndMark">
          —
         </span>
         In an infertile couple with a male partner who has a normal sperm concentration but abnormal sperm morphology and/or motility, referral to a specialist in ART, such as intracytoplasmic sperm injection (ICSI), might be useful. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'IVF with ICSI'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H590126666">
         <span class="h4">
          Sperm concentration &lt;5 million/mL
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because Klinefelter syndrome is common in men presenting with infertility and sperm concentrations &lt;5 million/mL, serum total testosterone (on a blood sample obtained between 8 and 10 AM), serum follicle-stimulating hormone (FSH), and luteinizing hormone (LH) measurements should be performed in these men [
         <a href="#rid5">
          5,14
         </a>
         ]. The results of the endocrine testing and details from the history and physical examination can help identify the cause of the infertility.
        </p>
        <p class="headingAnchor" id="H1382208927">
         <span class="h4">
          Severe oligozoospermia or azoospermia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Men with azoospermia or severe oligozoospermia also need endocrine testing; further evaluation also depends upon the results (see
         <a class="local">
          'Endocrine testing'
         </a>
         below). In addition to undergoing endocrine testing, men with severe oligozoospermia or azoospermia require genetic testing. (See
         <a class="local">
          'Genetic tests'
         </a>
         below.)
        </p>
        <p>
         Some men may require transrectal ultrasound for evaluation of obstructive azoospermia (those who have normal endocrine testing, normal testicular volume, palpable vasa deferentia on examination, and azoospermia). (See
         <a class="local">
          'Scrotal and transrectal ultrasound'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H861709662">
         <span class="h3">
          Endocrine testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         The endocrine assessment of an infertile man with a low sperm concentration (&lt;5 million/mL) includes measurements of serum total testosterone, LH, and FSH and other tests as clinically indicated [
         <a href="#rid15">
          15,16
         </a>
         ]. Serum total testosterone should be measured on a blood sample obtained between 8 and 10 AM. The measurement should be repeated in men with borderline values (see
         <a class="medical medical_review" href="/z/d/html/7462.html" rel="external">
          "Clinical features and diagnosis of male hypogonadism", section on 'Serum total testosterone'
         </a>
         ). The following combinations of serum testosterone, LH, and FSH suggest the following diagnoses:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Low testosterone, and high FSH and LH
         </strong>
         – Primary (hypergonadotropic) hypogonadism (affecting both spermatogenesis and Leydig cell function). These men should have a karyotype performed. Some experts do not recommend a karyotype if there is another clearly identified cause of primary hypogonadism. However, Klinefelter syndrome is common enough in infertile men with primary hypogonadism that karyotyping is reasonable even in the man with another cause of primary hypogonadism [
         <a href="#rid14">
          14,17
         </a>
         ]. (See
         <a class="local">
          'Genetic tests'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5309.html" rel="external">
          "Principles of magnetic resonance imaging"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Normal testosterone and LH and high
         </strong>
         <strong>
          FSH
         </strong>
         – Primary (hypergonadotropic) hypogonadism (seminiferous tubule damage without Leydig cell dysfunction). These men have isolated defects in spermatogenesis and intact sex hormone steroidogenesis with normal circulating testosterone concentrations. (See
         <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">
          "Causes of male infertility", section on 'Primary testicular defects in spermatogenesis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Low testosterone, but FSH and LH not elevated (normal or low)
         </strong>
         – Secondary (hypogonadotropic) hypogonadism. Serum prolactin should be measured in men with a low serum testosterone concentration, and normal to low serum LH and iron overload syndromes should be excluded with iron studies. Men with low serum testosterone and low gonadotropin concentrations should be evaluated for a sellar mass, other causes of secondary hypogonadism, and other pituitary hormone deficiencies (secondary hypothyroidism and hypoadrenalism). (See
         <a class="medical medical_review" href="/z/d/html/7462.html" rel="external">
          "Clinical features and diagnosis of male hypogonadism", section on 'Secondary hypogonadism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          High testosterone and LH, but normal FSH
         </strong>
         – Partial androgen resistance. (See
         <a class="medical medical_review" href="/z/d/html/7458.html" rel="external">
          "Pathogenesis and clinical features of disorders of androgen action"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Normal testosterone, LH, and FSH
         </strong>
         – Further evaluation depends upon findings on semen analysis (eg, azoospermia, oligozoospermia, asthenozoospermia, or teratozoospermia). (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'Normal serum T, normal LH and FSH'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Men with azoospermia and normal endocrine testing should be evaluated for ejaculatory duct obstruction. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'Obstruction of epididymis or ejaculatory duct'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Most infertile men who have normal serum testosterone concentrations, normal serum gonadotropin concentrations, and a primary defect in spermatogenesis have sperm in the ejaculate, but the numbers of sperm with normal motility and/or normal morphology are low. Clinicians should treat infertile men with oligozoospermia and normal serum hormones similarly to men with idiopathic infertility (ie, men with normal semen analyses and normal serum hormones). There is no clearly effective medical therapy for these men. Strategies include continuation of attempts at natural conception or ART. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'Assisted reproductive technologies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Low sperm count and very low LH in a man who is very muscular
         </strong>
         – Suspicious for androgen abuse. (See
         <a class="medical medical_review" href="/z/d/html/7475.html" rel="external">
          "Use of androgens and other hormones by athletes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2115939251">
         <span class="h3">
          Scrotal and transrectal ultrasound
         </span>
         <span class="headingEndMark">
          —
         </span>
         Scrotal or testicular ultrasound are useful if a patient has normal testicular volumes, normal serum testosterone, FSH, and LH, and azoospermia because the likely diagnosis is
         <strong>
          obstructive azoospermia
         </strong>
         . Scrotal or transrectal ultrasound should be done if the vasa differentia are not palpable on examination; this finding is important to confirm because it is associated with cystic fibrosis. Congenital absence of the vas deferentia may be the only manifestation of cystic fibrosis [
         <a href="#rid16">
          16
         </a>
         ]. Ejaculatory duct obstruction can be diagnosed by a scrotal or transrectal ultrasound showing dilated seminal vesicles [
         <a href="#rid18">
          18-21
         </a>
         ]. Transrectal ultrasound might be modestly more sensitive in detecting obstructive azoospermia [
         <a href="#rid22">
          22
         </a>
         ]. Patients with obstructive azoospermia should be referred to a urologist specialized in infertility for further evaluation and treatment. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'Obstructive azoospermia'
         </a>
         .)
        </p>
        <p>
         Although there is some controversy about the clinical significance of nonpalpable varicoceles in infertile men, it is not necessary to perform scrotal or transrectal ultrasound to detect small varicoceles because palpation is sufficient to detect large varicoceles that might be associated with male infertility [
         <a href="#rid5">
          5,7,23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3775721737">
         <span class="h3">
          Magnetic resonance imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Magnetic resonance imaging might be slightly more sensitive for detecting partial ejaculatory duct obstruction, but the expense of this imaging modality is not generally justifiable [
         <a href="#rid20">
          20,21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3361601011">
         <span class="h3">
          Genetic tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Karyotyping and testing for Y chromosome microdeletions should be done in infertile men with sperm concentrations &lt;5 million/mL before any ART therapy is performed [
         <a href="#rid5">
          5,14
         </a>
         ]. Klinefelter syndrome is common in these men, and chromosomal translocations occur in up to 15 percent of men with severe oligozoospermia or azoospermia [
         <a href="#rid5">
          5,14,24,25
         </a>
         ]. Men with absence of bilateral vasa differentia should be tested for gene mutations associated with cystic fibrosis (cystic fibrosis transmembrane conductance regulator [
         <em>
          CFTR
         </em>
         ]
         <em>
         </em>
         gene mutations) [
         <a href="#rid5">
          5
         </a>
         ]. ART has made it possible for men with severe oligozoospermia and azoospermia to pursue fertility, but there is a small risk of transferring somatic and sex chromosome abnormalities, microdeletions of the Y chromosome, X chromosome defects, and
         <em>
          CFTR
         </em>
         gene mutations to the offspring [
         <a href="#rid5">
          5,14,17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'Retrieval of sperm'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2243596411">
         <span class="h1">
          SEMEN ANALYSES
         </span>
        </p>
        <p class="headingAnchor" id="H967790467">
         <span class="h2">
          Semen analysis interpretation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most infertile men with abnormal semen analyses have abnormalities in sperm concentration, morphology, and motility.
        </p>
        <p class="headingAnchor" id="H2212752278">
         <span class="h3">
          Low volume
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low semen volume with
         <strong>
          normal sperm concentration
         </strong>
         is most likely due to incomplete collection of the ejaculate or partial retrograde ejaculation. The patient should be asked to return for a carefully collected repeat semen sample after emptying the bladder; post-ejaculation urine can be collected to assess whether there is retrograde ejaculation [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low semen volume and
         <strong>
          low sperm concentration
         </strong>
         may also be seen in some men with testosterone deficiency.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Endocrine assessment of possible testosterone deficiency is reviewed above. (See
         <a class="local">
          'Endocrine testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A low volume with
         <strong>
          azoospermia (no sperm) or severe oligozoospermia
         </strong>
         (severely subnormal sperm concentration) suggests genital tract obstruction (eg, congenital absence of the vas deferens and seminal vesicles, or ejaculatory duct obstruction). (See
         <a class="local">
          'Scrotal and transrectal ultrasound'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Congenital absence of vas deferens is suspected by physical examination and confirmed by scrotal or transrectal ultrasound.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ejaculatory duct obstruction is diagnosed by the finding of dilated seminal vesicles on scrotal or transrectal ultrasonography. (See
         <a class="local">
          'Scrotal and transrectal ultrasound'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2779284899">
         <span class="h3">
          Low concentration
         </span>
         <span class="headingEndMark">
          —
         </span>
         The lower reference limit for sperm concentration is 15 million/mL (95% CI 12-16) [
         <a href="#rid13">
          13
         </a>
         ] (see
         <a class="local">
          'Reference limits'
         </a>
         above). However, some men with sperm counts considered to be low can be fertile, while others above the lower limit of normal can be subfertile [
         <a href="#rid26">
          26-28
         </a>
         ]. In addition, for the purposes of in vitro fertilization (IVF), 10 million/mL or even less can be satisfactory [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lack of sperm in the ejaculate does not indicate the absence of sperm production; these patients should be evaluated for retrograde ejaculation, congenital absence of the vas deferens, and other causes of obstructive azoospermia. (See
         <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">
          "Causes of male infertility", section on 'Sperm transport disorders'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If few or no spermatozoa per high-power field are observed, there are special techniques to increase the sensitivity of detecting sperm in the ejaculate [
         <a href="#rid13">
          13,29
         </a>
         ]. Identifying even a few spermatozoa in the ejaculate is useful because it indicates that assisted reproductive technologies (ART) might be effective. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'IVF with ICSI'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1086576221">
         <span class="h3">
          Abnormal morphology
         </span>
         <span class="headingEndMark">
          —
         </span>
         The criteria for sperm morphology are based on length, width, width ratio, area occupied by the acrosome, and neck and tail defects [
         <a href="#rid13">
          13,30,31
         </a>
         ]. Sperm morphology assessment has modest clinical value [
         <a href="#rid32">
          32
         </a>
         ]. It is useful for detecting selected, very rare genetic causes of male infertility [
         <a href="#rid32">
          32
         </a>
         ]. It has been claimed that morphologic assessment has good predictive value for pregnancy rates after IVF [
         <a href="#rid30">
          30,31,33
         </a>
         ], but these claims are controversial and not well supported by clinical studies [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Round cells in the seminal fluid may be leukocytes, immature germ cells, or degenerating epithelial cells [
         <a href="#rid11">
          11
         </a>
         ]. Presence of immature germ cells in the semen usually indicates disorders of spermatogenesis. White blood cells, mainly polymorphonuclear leukocytes, are frequently present in the seminal fluid. Presence of increased white blood cells in the ejaculate may be a marker of genital infection/inflammation and may be associated with poor semen quality because of the release of reactive oxygen species from the leukocytes. The suggested cutoff for the diagnosis of a possible infection is one million leukocytes/mL of ejaculate. However, this cutoff has poor predictive value for bacterial infection [
         <a href="#rid34">
          34,35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3486107808">
         <span class="h3">
          Poor motility
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, motility is not an important factor in independently predicting the probability of natural pregnancy, unless a very high percentage of sperm in ejaculate are immotile [
         <a href="#rid36">
          36
         </a>
         ]. Men with a very high percentage of immotile sperm might still be treatable with intracytoplasmic sperm injection (ICSI) [
         <a href="#rid36">
          36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">
          "Treatments for male infertility", section on 'IVF with ICSI'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2977165723">
         <span class="h3">
          Prediction of fertility
         </span>
         <span class="headingEndMark">
          —
         </span>
         The standard semen analysis provides descriptive data that do not always distinguish fertile from infertile men [
         <a href="#rid36">
          36
         </a>
         ]. In one prospective study of 430 couples, among those with a sperm concentration ≥40 x 10
         <sup>
          6
         </sup>
         /mL, 65 percent achieved pregnancy compared with 51 percent of those with lower sperm concentrations [
         <a href="#rid37">
          37
         </a>
         ]. In a study of male partners in 765 infertile couples in which the female partners had normal infertility workup and in 696 control fertile couples recruited from prenatal classes, there was extensive overlap between fertile and infertile men in sperm concentration, motility, and morphology [
         <a href="#rid28">
          28
         </a>
         ]. However, men who have a "triple" defect of low sperm concentrations, low percentage of normal morphology, and low percentage of motile sperm have a high probability of infertility [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3199795168">
         <span class="h2">
          At-home test
         </span>
         <span class="headingEndMark">
          —
         </span>
         At-home testing of sperm quality is commercially available. We do not recommend these at-home tests in the evaluation of male infertility, because these tests do not assess sperm morphology and they have not been carefully studied for reliability [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H240921987">
         <span class="h2">
          Specialized sperm and semen tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest not doing specialized sperm and semen tests, such as antisperm autoantibodies, seminal fluid fructose, or semen culture.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of agglutination in the initial semen analysis suggests sperm autoantibodies that are present in 4 to 8 percent of infertile men [
         <a href="#rid11">
          11
         </a>
         ]. However, sperm autoantibodies do not appear to cause infertility. (See
         <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">
          "Causes of male infertility"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sperm biochemistry is frequently described in semen analyses but is rarely useful in clinical practice. The most commonly ordered test is fructose, which is a marker of seminal vesicle function, and seminal fructose might be low in men with ejaculatory duct obstruction [
         <a href="#rid40">
          40
         </a>
         ]. This test is not routinely used.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Semen culture is sometimes performed in men whose semen samples contain inflammatory cells, but semen culture results have not been proven to be useful.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are numerous other specialized sperm and semen tests (including tests of sperm DNA damage) that are used in some fertility clinics and laboratories, but these tests lack standardization and evidence to support their routine use [
         <a href="#rid36">
          36,41,42
         </a>
         ]. Tests of sperm DNA fragmentation might prove to be useful, but the evidence to support their use is based almost exclusively on retrospective studies, case series, and expert opinion [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3497592991">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115208.html" rel="external">
          "Society guideline links: Male infertility or hypogonadism"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3046706156">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15425.html" rel="external">
          "Patient education: Male infertility (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2180.html" rel="external">
          "Patient education: Treatment of male infertility (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3041926272">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Identify treatable causes
         </strong>
         –
         <strong>
         </strong>
         The evaluation of male infertility should focus on identifying treatable causes and factors that might affect the outcome of therapy or the health of offspring. (See
         <a class="local">
          'Diagnostic approach'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Female partner
         </strong>
         –
         <strong>
         </strong>
         The female partner must be evaluated thoroughly before or concurrent with the male partner of an infertile couple. (See
         <a class="local">
          'Initial visit'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Semen analysis
         </strong>
         –
         <strong>
         </strong>
         Semen analysis is the fundamental investigation for the infertile male and directs the subsequent evaluation. (See
         <a class="local">
          'Semen analysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         If the initial semen analysis has any abnormality, it should be repeated. If repeated semen analyses demonstrate a sperm concentration less than 5 million spermatozoa/mL, then serum testosterone, serum follicle-stimulating hormone (FSH), and luteinizing hormone (LH) should be measured. (See
         <a class="local">
          'Semen analysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Scrotal and transrectal ultrasound
         </strong>
         – Impalpable vasa deferentia on physical examination suggest congenital absence of vasa deferentia. This finding should be confirmed with ultrasound. These patients should be tested for the cystic fibrosis transmembrane conductance regulator (
         <em>
          CFTR
         </em>
         ) gene mutations, and, if positive in either the man or the female partner, genetic counseling should be offered before assisted reproductive technology (ART) therapies are performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Ejaculatory duct obstruction
         </strong>
         – If seminal fluid pH and volume are low (&lt;1.5 mL) in a man with azoospermia, normal-sized testes, and normal serum testosterone, FSH, and LH concentrations, retrograde ejaculation or ejaculatory duct obstruction is likely and a postejaculatory urine sample analysis and transrectal ultrasound imaging should be performed. (See
         <a class="local">
          'Scrotal and transrectal ultrasound'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic testing
         </strong>
         – Karyotyping and testing for Y chromosome microdeletions should be offered to all infertile men with sperm concentrations &lt;5 million/mL before any ART therapy is performed. (See
         <a class="local">
          'Genetic tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3710964290">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Ronald Swerdloff, MD, Christina Wang, MD, and Stephanie Page, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Practice Committee of tAmerican Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008; 90:S60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evers JL. Female subfertility. Lancet 2002; 360:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Annual Capri Workshop Group. Towards a more pragmatic and wiser approach to infertility care. Hum Reprod 2019; 34:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winters BR, Walsh TJ. The epidemiology of male infertility. Urol Clin North Am 2014; 41:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barratt CLR, Björndahl L, De Jonge CJ, et al. The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities. Hum Reprod Update 2017; 23:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruger TF, Acosta AA, Simmons KF, et al. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988; 49:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lotti F, Maggi M. Ultrasound of the male genital tract in relation to male reproductive health. Hum Reprod Update 2015; 21:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakamoto H, Saito K, Oohta M, et al. Testicular volume measurement: comparison of ultrasonography, orchidometry, and water displacement. Urology 2007; 69:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diamond DA, Paltiel HJ, DiCanzio J, et al. Comparative assessment of pediatric testicular volume: orchidometer versus ultrasound. J Urol 2000; 164:1111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mbaeri TU, Orakwe JC, Nwofor AM, et al. Accuracy of Prader orchidometer in measuring testicular volume. Niger J Clin Pract 2013; 16:348.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization Department of Reproductive Health and Research. World Health Organization Laboratory Manual for the Examination and Processing of Human Semen, 5th ed, World Health Organization, Geneva, Switzerland 2010.
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLachlan RI, Baker HW, Clarke GN, et al. Semen analysis: its place in modern reproductive medical practice. Pathology 2003; 35:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLachlan RI. Approach to the patient with oligozoospermia. J Clin Endocrinol Metab 2013; 98:873.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sokol RZ. Endocrinology of male infertility: evaluation and treatment. Semin Reprod Med 2009; 27:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anawalt BD. Approach to male infertility and induction of spermatogenesis. J Clin Endocrinol Metab 2013; 98:3532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofherr SE, Wiktor AE, Kipp BR, et al. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J Assist Reprod Genet 2011; 28:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meacham RB, Hellerstein DK, Lipshultz LI. Evaluation and treatment of ejaculatory duct obstruction in the infertile male. Fertil Steril 1993; 59:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarow JP. Transrectal ultrasonography in the diagnosis and management of ejaculatory duct obstruction. J Androl 1996; 17:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jurewicz M, Gilbert BR. Imaging and angiography in male factor infertility. Fertil Steril 2016; 105:1432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang IS, Wren J, Bennett NE, Brannigan RE. Clinical Consultation Guide on Imaging in Male Infertility and Sexual dysfunction. Eur Urol Focus 2018; 4:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdulwahed SR, Mohamed EE, Taha EA, et al. Sensitivity and specificity of ultrasonography in predicting etiology of azoospermia. Urology 2013; 81:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kroese AC, de Lange NM, Collins J, Evers JL. Surgery or embolization for varicoceles in subfertile men. Cochrane Database Syst Rev 2012; 10:CD000479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLachlan RI, O'Bryan MK. Clinical Review#: State of the art for genetic testing of infertile men. J Clin Endocrinol Metab 2010; 95:1013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin RH. Cytogenetic determinants of male fertility. Hum Reprod Update 2008; 14:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jørgensen N, Andersen AG, Eustache F, et al. Regional differences in semen quality in Europe. Hum Reprod 2001; 16:1012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swan SH, Brazil C, Drobnis EZ, et al. Geographic differences in semen quality of fertile U.S. males. Environ Health Perspect 2003; 111:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guzick DS, Overstreet JW, Factor-Litvak P, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001; 345:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper TG, Hellenkemper B, Jonckheere J, et al. Azoospermia: virtual reality or possible to quantify? J Androl 2006; 27:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menkveld R, Stander FS, Kotze TJ, et al. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 1990; 5:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruger TF, du Toit TC, Franken DR, et al. Sperm morphology: assessing the agreement between the manual method (strict criteria) and the sperm morphology analyzer IVOS. Fertil Steril 1995; 63:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gatimel N, Moreau J, Parinaud J, Léandri RD. Sperm morphology: assessment, pathophysiology, clinical relevance, and state of the art in 2017. Andrology 2017; 5:845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruger TF, Menkveld R, Stander FS, et al. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 1986; 46:1118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolff H. The biologic significance of white blood cells in semen. Fertil Steril 1995; 63:1143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lackner J, Schatzl G, Horvath S, et al. Value of counting white blood cells (WBC) in semen samples to predict the presence of bacteria. Eur Urol 2006; 49:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang C, Swerdloff RS. Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests. Fertil Steril 2014; 102:1502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonde JP, Ernst E, Jensen TK, et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998; 352:1172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Björndahl L, Kirkman-Brown J, Hart G, et al. Development of a novel home sperm test. Hum Reprod 2006; 21:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klotz KL, Coppola MA, Labrecque M, et al. Clinical and consumer trial performance of a sensitive immunodiagnostic home test that qualitatively detects low concentrations of sperm following vasectomy. J Urol 2008; 180:2569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dieudonné O, Godin PA, Van-Langendonckt A, et al. Biochemical analysis of the sperm and infertility. Clin Chem Lab Med 2001; 39:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zini A, Bach PV, Al-Malki AH, Schlegel PN. Use of testicular sperm for ICSI in oligozoospermic couples: how far should we go? Hum Reprod 2017; 32:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomlinson M, Lewis S, Morroll D, British Fertility Society. Sperm quality and its relationship to natural and assisted conception: British Fertility Society guidelines for practice. Hum Fertil (Camb) 2013; 16:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dutta S, Henkel R, Agarwal A. Comparative analysis of tests used to assess sperm chromatin integrity and DNA fragmentation. Andrologia 2021; 53:e13718.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7453 Version 22.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19007647" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Definitions of infertility and recurrent pregnancy loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12126838" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Female subfertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31241741" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Towards a more pragmatic and wiser approach to infertility care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24286777" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The epidemiology of male infertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28981651" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3335257" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Predictive value of abnormal sperm morphology in in vitro fertilization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25038770" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Ultrasound of the male genital tract in relation to male reproductive health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17270639" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Testicular volume measurement: comparison of ultrasonography, orchidometry, and water displacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10958754" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Comparative assessment of pediatric testicular volume: orchidometer versus ultrasound.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23771459" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Accuracy of Prader orchidometer in measuring testicular volume.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23771459" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Accuracy of Prader orchidometer in measuring testicular volume.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12701680" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Semen analysis: its place in modern reproductive medical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19934213" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : World Health Organization reference values for human semen characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23472228" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Approach to the patient with oligozoospermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19247916" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Endocrinology of male infertility: evaluation and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24014811" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Approach to male infertility and induction of spermatogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21912980" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8425637" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Evaluation and treatment of ejaculatory duct obstruction in the infertile male.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8957689" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Transrectal ultrasonography in the diagnosis and management of ejaculatory duct obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27125229" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Imaging and angiography in male factor infertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30327281" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Clinical Consultation Guide on Imaging in Male Infertility and Sexual dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23453653" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Sensitivity and specificity of ultrasonography in predicting etiology of azoospermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23076888" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Surgery or embolization for varicoceles in subfertile men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20089613" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Clinical Review#: State of the art for genetic testing of infertile men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18535003" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Cytogenetic determinants of male fertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11331653" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Regional differences in semen quality in Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12676592" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Geographic differences in semen quality of fertile U.S. males.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11794171" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Sperm morphology, motility, and concentration in fertile and infertile men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16598028" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Azoospermia: virtual reality or possible to quantify?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2394790" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The evaluation of morphological characteristics of human spermatozoa according to stricter criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7805902" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Sperm morphology: assessing the agreement between the manual method (strict criteria) and the sperm morphology analyzer IVOS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28692759" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Sperm morphology: assessment, pathophysiology, clinical relevance, and state of the art in 2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2946611" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Sperm morphologic features as a prognostic factor in in vitro fertilization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7750580" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The biologic significance of white blood cells in semen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16314032" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Value of counting white blood cells (WBC) in semen samples to predict the presence of bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25458617" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9777833" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16267078" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Development of a novel home sperm test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18930494" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Clinical and consumer trial performance of a sensitive immunodiagnostic home test that qualitatively detects low concentrations of sperm following vasectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11434397" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Biochemical analysis of the sperm and infertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27816927" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Use of testicular sperm for ICSI in oligozoospermic couples: how far should we go?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23862664" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Sperm quality and its relationship to natural and assisted conception: British Fertility Society guidelines for practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32628294" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Comparative analysis of tests used to assess sperm chromatin integrity and DNA fragmentation.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
